In a study published the journal Nature Communications, researchers reveal how the drug mefenamic acid reversed memory loss in mouse models of Alzheimer’s disease by reducing brain inflammation. Study leader Dr. David Brough, of the University of Manchester in the United Kingdom, and his team say their results open the door to trials in humans